An Open-label Study of a HAART (Highly Active Antiretroviral Therapy) Regimen Containing Subcutaneous Injection of Fuzeon on Quality of Life in Clinically Stable, Treatment-experienced Patients With HIV-1 Infection
Phase of Trial: Phase IV
Latest Information Update: 23 May 2013
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms QUALITE
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 23 May 2013 Last checked against ClinicalTrials.gov.
- 27 Jan 2006 New trial record.